Please ensure Javascript is enabled for purposes of website accessibility

Argenta Appoints Jean Hoffman to Its Board of Directors

Argenta Appoints Jean Hoffman to Its Board of Directors

Serial entrepreneur with extensive experience in global pharmaceutical, veterinary, and health care information technology industries, brings valuable knowledge and strategic acumen to the Argenta board.

Argenta announced today the appointment of Jean Hoffman, an accomplished animal health executive and strategist, to its board of directors. Her appointment increases the size of the Board from five to six members.

“We are pleased to welcome Jean to the Board. As Argenta focuses on accelerating its growth strategy and builds on the vision to become the leading global animal health services company, she brings invaluable expertise to our Board,” said George Gunn, chairman of Argenta’s board of directors. “Jean has an exceptional track record of leadership, strategy, business growth and team building, and I look forward to her contributions and insights.”

Jean Hoffman is a serial entrepreneur and visionary leader with extensive experience in global pharmaceutical, veterinary, and health care information technology. She was the founder of Putney and built the company into America’s leading generic drug company for pets. Jean chaired the Board of Directors and led the company as President and CEO from inception to the 2016 sale to Dechra Holdings US Inc. Prior to Putney, she founded and built Newport Strategies, Inc., which was acquired by Thomson Reuters (NYSE-TRI) in 2004.

In her career, Jean has been honored with numerous awards, including several for science and technology leadership. In addition, she has been recognized by shareholders, business partners, independent judges, customers and team members for ground breaking strategy, visionary leadership, successful entrepreneurship, astute risk management and excellence in communications.

Jean’s career began at the Washington, DC based, public/private U.S.-China Business Council in 1980, where she advised U.S. companies on the establishment of business with China and Chinese entities on exporting to the U.S, commencing her career in the pharmaceutical industry.

“I am excited by Argenta’s growth prospects, having watched the company since my days as Putney CEO. I look forward to working with Chairman George Gunn and my colleagues on the board as well as the management team to contribute to Argenta’s success,” said Jean Hoffman.

With this appointment, the Board consists of six members: chairman George Gunn, Kugan Sathiyanandarajah, Managing Director at KKR; Johnny Kim, Director at KKR; MarkGibson, Tomlinson Group; David Geor, Tomlinson Group; and Jean Hoffman.


About Argenta

Argenta is the only combined global contract research organization (CRO) and contract development and manufacturing organization (CDMO) dedicated to animal health. Founded in 2006 in New Zealand, Argenta’s talented, diverse and committed employees work on a daily basis to deliver excellence in animal health to customers around the world. With research and GMP manufacturing operations in New Zealand, the United States and the United Kingdom, Argenta operates ‘from Molecule to Market’ in partnership with its customers to support their R&D, regulatory, clinical research and manufacturing needs along the veterinary product development journey. For more information about Argenta, please visit


Press Contact

Annemieke de Keijzer
+1 732-439-3446

Continue Reading